Product Suite 
& Solutions

Overview

 

Precision NanoSystems’ proprietary NanoAssemblr® Platform with NxGen™ technology enables time-invariant particle formation to ensure the most reproducible results for a wide range of particle types. NxGen is the only technology that can scale a single mixer from mL / min to L / h

NxGen logo

A Disruptive Technology Enabling Transformative Medicine

Nanoparticle, Liposome, LNP
The Evolution of NxGen Technology
The Evolution of NxGen
From Bench to Commercial Scale

The NxGen mixer uses precisely controlled mixing to reproducibly generate optimal particles through a single mixer across scales.

 



Non-turbulent Mixing

This differs from turbulent mixing where collisions are used to speed mixing. These are extremely dependent on geometric and velocity profiles which differ at scale.


The proprietary NxGen microfluidic mixer at the heart of NanoAssemblr systems is designed exclusively for nanomedicine development and is capable of > 25x  throughput of our Classic (formerly know as SHM) mixer.

Discovery

药物发现

The
NanoAssemblr®
Spark

With

NxGen Icon 

Technology



Freedom to Discover
With Instant Microliter
Nanomedicine Formulations

Learn More
NanoAssemblr Spark
sample-recovery
Unmatched
Sample Recovery

Advanced microfluidics allows microliter formulation volumes with near complete sample recovery.

intuitive-operation
Intuitive Operation

Simply pipette starting materials into wells, push a button, and pipette completed formulations out.

rapid-production

Rapid Production

The Spark formulation process requires less than 5 seconds, allowing hundreds of formulations to be made in hours.

robust-process

Robust Process

Electronic control minimizes batch-to-batch and user variability.

workflow-integration
Workflow Integration

The Spark system is designed for operation in a sterile biosafety hood, so formulations can be made on-demand, and applied to cells in culture.

scalable

Scalable

Shared microfluidic mixing technology allows formulations to be scaled across the NanoAssemblr Platform to accelerate future development.

Preclinical

临床前研究

The
NanoAssemblr®
Benchtop
Develop Future Nanomedicines

Learn More
NanoAssemblr Benchtop
outstanding-reproducibility
Outstanding
Reproducibility

Computer control removes batch-to-batch and user variability

intuitive-operation

Intuitive Workflow

Advanced microfluidics are simplified with easy connections and visual software

controlled-assembly

Controlled Assembly

Tune particle size with precise control over fluid flow rates

versatile

Versatile

Formulate small molecules, peptides, and nucleic acids into lipid, polymer or hybrid nanoparticles, and more.

speedy

Speedy and Efficient

Formulation runs require less than a minute. 30 - 40 formulations can be completed in a day for rapid optimization.

scalable

Scalable

Easily scale between 1mL and 15mL formulations on the Benchtop. Optimized formulations can be transferred to advanced preclinical and clinical scale with the Blaze™ and GMP Systems.

The
NanoAssemblr®
Blaze

With

NxGen Icon

Technology



Advance Preclinical
Nanomedicine Programs


Learn More
NanoAssemblr Blaze

speedy

Speedy and Efficient

Formulation runs require less than a minute. 30 - 40 formulations can be completed in a day for rapid optimization.

Untitled-2

Easy Scale-up

Easy scale-up of formulations developed on the NanoAssemblr® Benchtop.

rapid-production

High capacity

Greater formulation capacity with the simplicity and efficiency of the NanoAssemblr Benchtop.

Untitled-3

Validation
of inline dilution

Validation of Inline Dilution up to 5L.

controlled-assembly

high range
of formulation

Formulation of 10 mL to 1L batches.

Untitled-4

Scalable upstream
and downstream

Scale-up development of upstream and downstream processes.

Manufacturing

制备

GMP System

With

NxGen Icon

Technology



NanoAssemblr GMP System: Is a modular and configurable system, fit-for-purpose and phase appropriate, for the GMP manufacturing of nanomedicines.

 

Continuous flow microfluidic platform designed for scale-up manufacturing of nanoparticles under cGMP conditions. The GMP system’s formulation results are in sync with NanoAssemblr Benchtop and Blaze-generated particles.

Learn More
GMP System
Polymeric Nanoparticle
What is Nanomedicine?
Nanomedicines represent the next paradigm in drug innovation, and current research has demonstrated improved efficacy, reduced side effects and revolutionary new treatment modalities like gene therapy and targeted medicine.

Get Started

To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.

Get in Touch

Resource Center

Publication - Summary

May 18, 2019

Annals of Hematology

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

N. Jyotsana, A. Sharma, A. Chaturvedi, et al.

Read More 阅读更多

Publication - Summary

May 17, 2019

Science Immunology

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

N. Kose, J.M. Fox, G. Sapparapu, et al.

Read More 阅读更多

Publication - Summary

April 04, 2019

The Journal of Neuroscience

PTCD1 is required for mitochondrial oxidative-phosphorylation: possible genetic association with Alzheimer's disease

D. Fleck, L. Phu, E. Verschueren, T. Hinkle, M. Reichelt, T. Bhangale, B. Haley, Y. Wang, R. Graham, D.S. Kirkpatrick, M...

Read More 阅读更多

Publication - Summary

February 07, 2019

Nano Research

Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast can...

C. Zhang, X. Zhang, W. Zhao, C. Zeng, W. Li, B. Li, X. Luo, J. Li, J. Jiang, B. Deng, D.W. McComb, Y. Dong

Read More 阅读更多

Application Note

January 16, 2019

mRNA Lipid Nanoparticles: Robust low-volume production for screening high-value nanoparticle materials

Read More 阅读更多 PDF

Publication - Summary

September 24, 2018

Nucleic Acid Therapeutics

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

R. Jain, JP. Frederick, EY. Huang, KE. Burke, DM. Mauger, EA. Andrianova, SJ. Farlow, S. Siddiqui, J. Pimentel, K. Cheun...

Read More 阅读更多
Resource Center 资源中心
MENU
菜单
X
X